Question

What is the best country for stem cell therapy for COPD & Lung Disease?

There is no evidence-based best country. Compare authorised protocol, pulmonary expertise, exact product and manufacturing, objective respiratory endpoints, oxygen and emergency capability and long-term adverse-event follow-up.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

The cost picture for COPD & Lung Disease

Itemise respiratory assessment, product, administration, pulmonary rehabilitation, medicines, oxygen, travel, follow-up and management of infection, exacerbation or hospitalisation. A commercial infusion quote is not comparable with long-term evidence-based COPD care and must not divert resources from smoking cessation or established treatment.

Am I a candidate? → · COPD & Lung Disease: full overview → · COPD & Lung Disease cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information